Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001362310-08-006339
Filing Date
2008-10-30
Accepted
2008-10-30 06:01:09
Documents
5
Period of Report
2008-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c76471e10vk.htm 10-K 720797
2 EXHIBIT 23.1 c76471exv23w1.htm EX-23.1 1181
3 EXHIBIT 31.1 c76471exv31w1.htm EX-31.1 5122
4 EXHIBIT 31.2 c76471exv31w2.htm EX-31.2 5151
5 EXHIBIT 32.1 c76471exv32w1.htm EX-32.1 3154
  Complete submission text file 0001362310-08-006339.txt   736989
Mailing Address 9 COMMERCIAL BLVD, SUITE 200 NOVATO CA 94949
Business Address 9 COMMERCIAL BLVD, SUITE 200 NOVATO CA 94949 415-382-1390
RAPTOR PHARMACEUTICALS CORP. (Filer) CIK: 0001203944 (see all company filings)

EIN.: 980379351 | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 000-50720 | Film No.: 081149053
SIC: 2834 Pharmaceutical Preparations